ScholarIQanswers from OpenAlex

Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility

PaperCitations, authors & open-access status

Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility have?

ScholarIQcitation count

Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility has 68 citations in the OpenAlex counts ScholarIQ stores.

When was Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility published?

ScholarIQyear

Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility has 2018 year in the ScholarIQ index.

What is the open-access status of Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility?

ScholarIQoa status

Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility has closed oa status in the ScholarIQ index.

What is the DOI of Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility?

ScholarIQdoi

The DOI for Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility is on the source record.

What is the PMID of Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility?

ScholarIQpmid

The PMID for Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility is on the source record.

What is the OpenAlex record for Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility?

ScholarIQopenalex

The OpenAlex for Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial